Superiority of bixalomer (Kiklin) as phosphate binder and impact on lipid metabolism in HD patients (Skip-study)
Not Applicable
- Conditions
- Hemodialysis patients with hyperphosphatemia
- Registration Number
- JPRN-UMIN000009246
- Lead Sponsor
- Juntendo University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients are excluded if they are compatible with any one of the following criteria. 1,Patients with a history of hypersensitivity for an ingredient of this medicine 2,Patients with bowel obstruction (for a non-absorbable polymer, we might raise intestinal perforation) 3,Patients with significant psychic disturbance or drug dependence disease or alcoholism 4,Patients that going to hospital of all follow-up seems to be impossible 5,Patients who are not able to understand a test instructions from medical experts of the client side or the doctors involved in the study 6,Patients who judged as inadequate by the doctors involved in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum phosphorus concentrations
- Secondary Outcome Measures
Name Time Method Evaluation of efficacy 1.Lipid metabolism:T-Cho,TG,HDL-C,RLP-C 2.Blood gas concentrations 3.Abdominal symptoms evaluation 4.Drug remedy time estimation 5.Adverse events